Cephalosporin drugs market
Cephalosporin Drugs Market, By Generation (First-generation, Cephalosporin, Second-generation Cephalosporin, Third-generation Cephalosporin, Fourth-generation Cephalosporin, and Fifth-generation Cephalosporin), By Type (Branded Cephalosporin Drugs and Generic Cephalosporin Drugs), By Formulation (Oral (Tablets, Capsules, and Liquid) and Injection), By Indication (Respiratory Tract Infection, Skin Infection, Ear Infection, Bacterial Infection, Urinary Tract Infection, Sexually Transmitted Infection, Sinus Infection, Surgical Prophylaxis, and Others (Meningitis, Acute Abdomen Infection, and Pelvic infection)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2019 - 2026
- Jul 2019
- CMI2893
- 236 Pages
- Excel & Pdf
- Pharmaceutical
Cephalosporin is a large group of antibiotics that belongs to a class known as beta-lactams. Cephalosporin is a wide spectrum bactericidal antibiotic used for the treatment of several bacterial infections. Cephalosporin drugs are available as both branded and generic medicines. Different generations of cephalosporin are used and preferred for different indications. The third-generation is the most prescribed and broad-spectrum antimicrobial agents useful in a variety of clinical situations. Cefotaxime and ceftizoxime have the best gram-positive bactericidal activity of the third-generation cephalosporin. Ceftazidime and cefoperazone are the only third-generation drugs that provide anti-pseudomonal coverage. Ceftriaxone's long half-life allows for once-daily dosing, making ceftriaxone an excellent drug for outpatient antibiotic therapy of community-acquired infections.
The global cephalosporin drugs market size was valued at US$ 14,240.0 million in 2018, and is expected to witness a CAGR of 3.8% over the forecast period (2019 – 2026).
Global Cephalosporin Drugs Market Share (%) Analysis, By Generation, 2018 & 2026
Source: Coherent Market Insights Analysis (2019)
Increasing Drug Approvals and R&D Activities is expected to Drive Growth of the Cephalosporin Drugs Market
Approvals and launch of novel products is expected to be a major factor driving the global cephalosporin drugs market growth over the forecast period. For instance, in June 2019, Merck & Co. announced that the U.S. Food and Drug Administration (FDA) approved its supplemental New Drug Application (sNDA) for the use of ZERBAXA (ceftolozane and tazobactam) for the treatment of patients 18 years and older with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.
Increasing research and development activities has spurred growth of the cephalosporin drugs market. For instance, in November 2017, B. Braun Medical Inc. initiated a clinical trial of Cefazolin infusion evaluating the safety of 1 g and 2 g of Cefazolin in pediatric subjects. The study is in phase 4 and is expected to be completed in July 2019. Therefore, increasing research on cephalosporin drugs is expected to create a favorable environment for the cephalosporin drugs market growth over the forecast period.
Global Cephalosporin Drugs Market - Restraints
Increasing cephalosporin drug recalls by regulatory bodies is hampering the cephalosporin drugs market growth. For instance, in August 2014, Caraco Pharmaceutical Laboratories Ltd., a unit of Sun Pharmaceutical Industries Ltd., initiated a recall of multiple lots of Cephalexin capsules from the U.S. market. According to a notification by the U.S. FDA, the recall of 340,553 units of 500 mg and 113,677 units of 250 mg bottles was voluntarily initiated by the company through a letter to the regulator in June 2014 under ‘Class-II’ classification, owing to Current Good Manufacturing Practice (CGMP) deviations.
Global Cephalosporin Drugs Market - Regional Insights
On the basis of region, the global cephalosporin drugs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global cephalosporin drugs market during the forecast period, owing to increasing number of product launches. For instance, in August 2017, Dr. Reddy’s Laboratories Ltd. launched Cefixime for Oral Suspension, a therapeutic equivalent generic version of Suprax (cefixime) for Oral Suspension, in the U.S. market. The Suprax brand and generic had US sales of approximately US$ 50.5 million for the 12 months ended in June 2017.
Asia Pacific is expected to foresee a rapid growth in the cephalosporin drugs market. The market in Asia Pacific is expected to gain momentum during the forecast period, owing to increasing strategic partnership for distribution of cephalosporin drugs. For instance, in September 2017, Basilea Pharmaceutica Ltd. announced that its subsidiary, Basilea Pharmaceutica International Ltd. (Basilea), entered into a license agreement with Shenzhen China Resources Gosun Pharmaceutical Co., Ltd. for Basilea's antibiotic Zevtera (ceftobiprole) in China.
Global Cephalosporin Drugs Market Value (US$ Mn) & Y-o-Y Growth (%), 2019-2026
Source: Coherent Market Insights Analysis (2019)
Key players operating in the global cephalosporin drugs market include, Merck & Co. Inc., GlaxoSmithKline plc., Pfizer Inc., Allergan plc., Abbott Laboratories, Basilea Pharmaceutica Ltd., Sanofi S.A., F. Hoffmann-La Roche AG, Lupin Limited, Teva Pharmaceutical Industries Ltd., and B. Braun Melsungen AG.
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Generation
- Market Snippet, By Type
- Market Snippet, By Formulation
- Market Snippet, By Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Major Brand Analysis
- Reimbursement Scenario
- Epidemiology Analysis
- Porter’s Five Forces Model
- Pipeline Analysis
- Switch Analysis
- Site Chain Analysis
- Global Cephalosporin Drugs Market
- Antibiotic Resistance Trends By Country
- Global Cephalosporin Drugs Market, By Generation, 2019 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2019 and 2026 (%)
- Y-o-Y Growth Analysis, 2018 – 2026
- Segment Trends
- First-generation Cephalosporin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
- Second-generation Cephalosporin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
- Third-generation Cephalosporin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
- Fourth-generation Cephalosporin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
- Fifth-generation Cephalosporin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
- Global Cephalosporin Drugs Market, By Type, 2019 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2019 and 2026 (%)
- Y-o-Y Growth Analysis, 2018 – 2026
- Segment Trends
- Branded Cephalosporin Drugs
- Market Share Analysis, 2019 and 2026 (%)
- Y-o-Y Growth Analysis, 2018 – 2026
- Segment Trends
- Generic Cephalosporin Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
- Global Cephalosporin Drugs Market, By Formulation, 2019 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2019 and 2026 (%)
- Y-o-Y Growth Analysis, 2018 – 2026
- Segment Trends
- Oral
- Market Share Analysis, 2019 and 2026 (%)
- Y-o-Y Growth Analysis, 2018 – 2026
- Segment Trends
- Tablets
- Capsules
- Liquid
- Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
- Global Cephalosporin Drugs Market, By Indication, 2019 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2019 and 2026 (%)
- Y-o-Y Growth Analysis, 2018 – 2026
- Segment Trends
- Respiratory Tract Infection
- Market Share Analysis, 2019 and 2026 (%)
- Y-o-Y Growth Analysis, 2018 – 2026
- Segment Trends
- Skin Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
- Ear Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
- Bacterial Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
- Urinary Tract Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
- Sexually Transmitted Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
- Sinus Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
- Surgical Prophylaxis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
- Others (Meningitis, Acute Abdomen Infection, and Pelvic Infection)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
- Global Cephalosporin Drugs Market, By Distribution Channel, 2019 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, 2019 and 2026 (%)
- Y-o-Y Growth Analysis, 2018 – 2026
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 – 2026, (US$ Million)
- Global Cephalosporin Drugs Market, By Region, 2019 – 2026, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2019 and 2026 (%)
- Y-o-Y Growth Analysis, By Region, 2018 – 2026
- Regional Trends
- North America
- Market Size and Forecast, By Generation, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Type, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Formulation, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Indication, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2019 – 2026, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Generation, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Type, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Formulation, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Indication, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2019 – 2026, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Generation, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Type, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Formulation, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Indication, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2019 – 2026, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Generation, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Type, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Formulation, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Indication, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2019 – 2026, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Generation, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Type, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Formulation, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Indication, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Country/Region, 2019 – 2026, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Middle East
- Market Size and Forecast, By Generation, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Type, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Formulation, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Indication, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2019 – 2026, (US$ Million)
- Market Size and Forecast, By Country, 2019 – 2026, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East
- Competitive Landscape
- Company Profiles
- Merck & Co. Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- GlaxoSmithKline plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Allergan plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Basilea Pharmaceutica Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Sanofi S.A.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- F. Hoffmann-La Roche AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Lupin Limited
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- B. Braun Melsungen AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Analyst Views
- Section
- References
- Research Methodology
- About Us and Sales Contact
*Browse 53 market data tables and 50 figures on "Cephalosporin Drugs Market” - Global forecast to 2026”